Skip to main content
. 2014 Apr;27(2):302–345. doi: 10.1128/CMR.00111-13

TABLE 5.

Suggested antimicrobials for treatment of PJIa

Microorganism(s) Preferred treatment Alternate treatment Combination therapyb
Methicillin-susceptible staphylococci Cefazolin or nafcillin Vancomycin, daptomycin, or linezolid Rifampin for DAIR and one-stage exchange
Methicillin-resistant staphylococci Vancomycin Daptomycin or linezolid Rifampin for DAIR and one-stage exchange
Penicillin-susceptible enterococci Penicillin or ampicillin Vancomycin, daptomycin, or linezolid Consider aminoglycoside
Penicillin-resistant enterococci Vancomycin Daptomycin or linezolid Consider aminoglycoside
Pseudomonas aeruginosa Cefepime or meropenem Ciprofloxacin or ceftazidime Consider aminoglycoside or fluoroquinolone
Enterobacter species Cefepime or ertapenem Ciprofloxacin No
Enterobacteriaceae Beta-lactam or ciprofloxacin No
Beta-hemolytic streptococci Penicillin or ceftriaxone No
Propionibacterium acnes Penicillin or ceftriaxone No
a

All antimicrobials are to be given intravenously, except ciprofloxacin or linezolid. (Adapted from reference 60 by permission of Oxford University Press/Infectious Diseases Society of America.)

b

DAIR, debridement, antibiotics, and implant retention.